Javascript must be enabled to continue!
Recurrent Vulvovaginal Candidiasis
View through CrossRef
Vulvovaginal candidiasis is a common fungal infection caused by Candida Sp, especially Candida albicans. Recurrent vulvovaginal candidiasis was defined as the occurrence of four or more episodes of vulvovaginal candidiasis in 12 months period. As many as 9% of women from various populations have recurrent vulvovaginal candidiasis. Vulvovaginal candidiasis affects the quality of life, mental health, and sexual activity. There are many predisposing factors that caused recurrent vulvovaginal candidiasis, such as genetics, host, habit, idiopathic and non-albican candida microbes. Management of recurrent vulvovaginal candidiasis includes elimination of predisposing factors; mycological culture diagnosis and identification of specific Candida species; followed by microbiological examination to confirm the sensitivity of the azole group to Candida sp. Further, oral, or topical therapy should be continued until the patient is asymptomatic and culture-negative. Patients should receive induction therapy followed by maintenance suppressive therapy for six months.
Hanif Medisiana Publisher
Title: Recurrent Vulvovaginal Candidiasis
Description:
Vulvovaginal candidiasis is a common fungal infection caused by Candida Sp, especially Candida albicans.
Recurrent vulvovaginal candidiasis was defined as the occurrence of four or more episodes of vulvovaginal candidiasis in 12 months period.
As many as 9% of women from various populations have recurrent vulvovaginal candidiasis.
Vulvovaginal candidiasis affects the quality of life, mental health, and sexual activity.
There are many predisposing factors that caused recurrent vulvovaginal candidiasis, such as genetics, host, habit, idiopathic and non-albican candida microbes.
Management of recurrent vulvovaginal candidiasis includes elimination of predisposing factors; mycological culture diagnosis and identification of specific Candida species; followed by microbiological examination to confirm the sensitivity of the azole group to Candida sp.
Further, oral, or topical therapy should be continued until the patient is asymptomatic and culture-negative.
Patients should receive induction therapy followed by maintenance suppressive therapy for six months.
Related Results
<b>Association Between Recurrent Vulvovaginal Candidiasis and Glycemic Control in Women With Undiagnosed Prediabetes</b>
<b>Association Between Recurrent Vulvovaginal Candidiasis and Glycemic Control in Women With Undiagnosed Prediabetes</b>
Background: Recurrent vulvovaginal candidiasis is a common gynecologic problem that causes repeated symptoms, frequent healthcare visits, and substantial impairment in quality of l...
Data from Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities
Data from Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities
<div>Abstract<p>Genital tract infections, including vulvovaginal candidiasis and bacterial vaginosis, have emerged as potential modulators of persistent human papilloma...
Data from Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities
Data from Bacterial Vaginosis Decreases the Risk of Cervical Cytological Abnormalities
<div>Abstract<p>Genital tract infections, including vulvovaginal candidiasis and bacterial vaginosis, have emerged as potential modulators of persistent human papilloma...
Recurrent Vulvovaginal Candidiasis
Recurrent Vulvovaginal Candidiasis
Vulvovaginal candidiasis is a common fungal infection caused by Candida Sp,especially Candida albicans. Recurrent vulvovaginal candidiasis was defined asthe occurrence of four or m...
Oral versus topical maintenance antifungal therapy for recurrent vulvovaginal candidiasis: A systematic review and meta-analysis
Oral versus topical maintenance antifungal therapy for recurrent vulvovaginal candidiasis: A systematic review and meta-analysis
Abstract
Background
Recurrent vulvovaginal candidiasis is a substantial personal and healthcare burden. This systematic review ...
The Association Between Vaginal Candidiasis and Health-promoting Lifestyle in Iranian Women: A Cross-sectional Study
The Association Between Vaginal Candidiasis and Health-promoting Lifestyle in Iranian Women: A Cross-sectional Study
Objectives: Vulvovaginal candidiasis is the second most common gynecological infection in the world that can bring about unfavorable consequences for the health and life of the wom...
The Validity of Point-of-Care Test (POCT) Lateral Flow Immunochromatographic Assay (LFIA) Candida albicans for the Diagnosis of Vulvovaginal Candidiasis
The Validity of Point-of-Care Test (POCT) Lateral Flow Immunochromatographic Assay (LFIA) Candida albicans for the Diagnosis of Vulvovaginal Candidiasis
Background: Vulvovaginal candidiasis is one of the most common causes of complaints of vaginal discharge, which is mostly caused by Candida albicans. The common diagnosis of vulvov...
untitled protocol v1
untitled protocol v1
Objective: To characterize the lipid profile in vaginal discharge of women with vulvovaginal candidiasis, cytolytic vaginosis, or no vaginal infection or dysbiosis. Design: Cross...

